Differential Sensitivity Analysis for Resistant Malignancies (DISARM) Identifies Common Candidate Therapies Across Platinum-Resistant Cancers

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-1129
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Targeted Treatment of Recurrent Platinum-Resistant Ovarian Cancer: Current and Emerging Therapies

Cancer Management and Research
Oncology
2010English

Scaffold Targeting Drug-Resistant Colon Cancers

English

Mp84-20 Bioinformatic Analysis Utilizing the Androgenic Suppressive Effect Identified Promising Candidate Drugs for Reprogramming Docetaxel-Resistant Castration-Resistant Prostate Cancer

Journal of Urology
Urology
2016English

Prm212 - Patient Experience With Platinum-Resistant or Platinum-Refractory Ovarian Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Oral Melphalan as a Treatment for Platinum-Resistant Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2003English

Is HIPEC Beneficial in Platinum Resistant Relapsed Ovarian Cancer?

Romanian Journal of Medical Practice
2019English

Dendritic Cell Therapies for Hematologic Malignancies

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2017English

Drug Repurposing Identifies Inhibitors of Oseltamivir-Resistant Influenza Viruses

Angewandte Chemie - International Edition
CatalysisChemistry
2016English

Analysis of the Molecular Epidemiology and Antibiotic Sensitivity of Vancomycin-Resistant Enterococci

Gaziantep Medical Journal
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy